Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/82068
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Comment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? |
Author: | Deane, A. Horowitz, M. |
Citation: | Diabetes Care, 2014; 37(2):e40-e41 |
Publisher: | American Diabetes Association |
Issue Date: | 2014 |
ISSN: | 0149-5992 1935-5548 |
Statement of Responsibility: | Adam M. Deane and Michael Horowitz |
Keywords: | Humans Diabetes Mellitus, Type 2 Receptors, Glucagon Incretins |
Rights: | © 2014 by the American Diabetes Association |
DOI: | 10.2337/dc13-1616 |
Published version: | http://dx.doi.org/10.2337/dc13-1616 |
Appears in Collections: | Anaesthesia and Intensive Care publications Aurora harvest |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_82068.pdf | Accepted version | 120.43 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.